Based near Atlanta, EndoChoice (NYSE: GI) is a medtech company focused on the manufacturing and commercialization of platform technologies including endoscopic imaging systems, devices and infection control products and pathology services for specialists diagnosing and treating a wide range of gastrointestinal conditions, including colon cancer. EndoChoice leverages its direct sales organization to serve more than 2,500 customers in the United States and works with distribution partners in 25 countries. The Company was founded in 2008 and has rapidly developed a broad and innovative product portfolio, which includes the Full Spectrum Endoscopy System (Fuse®).
Company Details
- Employees
- 73
- Founded
- -
- Address
- 11810 Wills Road, Alpharetta,ga 30009,united States
- Phone
- 7709626981
- sa****@****ice.com
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- endochoice.com
- Keywords
- Imaging, Devices, Diagnostics, Infection Control.
- HQ
- Alpharetta, GA
Endochoice Questions
Endochoice's helpline number is 7709626981
Endochoice's website is endochoice.com
Endochoice's LinkedIn profile is https://www.linkedin.com/company/endochoice
Endochoice has
73 employees.
View email and phone details for 73
employees at Endochoice.
Endochoice's industry is
Medical Equipment Manufacturing
Endochoice's top competitors are
Btg Plc,
Baylis Medical,
Ge Healthcare,
Medtronic,
Lydus Medical,
Boston Scientific,
Farapulse, Inc.,
Motus Gi Medical Technologies,
Thoracent,
Abbott.
Endochoice's support email address is sales@endochoice.com
Endochoice's categories are Medical Equipment Manufacturing
Endochoice's founding year is 2008
